AS THE NEW CORONAVIRUS spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem from the global pandemic, one industry is not only surviving but also profiting handsomely.
Pharmaceutical companies view COVID-19 as a once-in-a-lifetime business opportunity. The world needs pharmaceutical products, of course. For the new coronavirus outbreak, in particular, we need treatments and vaccines and, in the U.S., tests. Dozens of companies are now vying to make them.

On the Good Intention Show, we will have Dr. Shiva, an inventor of email, and a candidate for the Senate in Massachusetts talks about the sustainable development goals.